Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ketoprofen topical - Achelios Therapeutics

Drug Profile

Ketoprofen topical - Achelios Therapeutics

Alternative Names: ELS M11; Ketoprofen 2% gel – Achelios Therapeutics; Ketoprofen 5% gel – Achelios Therapeutics; Ketoprofen liquid spray – Achelios Therapeutics; Topofen™

Latest Information Update: 04 Oct 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Achelios Therapeutics
  • Class Analgesics; Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Migraine; Temporomandibular joint dysfunction syndrome
  • Discontinued Osteoarthritis; Sprains

Most Recent Events

  • 04 Oct 2022 Discontinued - Phase-I for Osteoarthritis in USA (Topical) (Achelios Therapeutics pipeline, October 2022)
  • 04 Oct 2022 Discontinued - Preclinical for Sprains in USA (Topical) (Achelios Therapeutics pipeline, October 2022)
  • 04 Oct 2022 Phase-II clinical trials in Temporomandibular joint dysfunction syndrome in USA (Topical) Before 2022 (Achelios Therapeutics pipeline, October 2022)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top